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Introduction
Parotid neoplasms are the most frequent salivary 
gland tumors; 60% of them are benign and are mainly 
located in the superficial lobe (76% of cases), while 
malignant lesions usually involve the deep lobe or both 
lobes. Tumor location, extension and correct preopera-
tive characterization play a crucial role in deciding the 
proper treatment [1-4].
Surgical treatment of parotid tumors ranges from 
extracapsular dissection to total parotidectomy with or 
without neck dissection [5-11]. Characterization of pa-
rotid tumors is relevant in planning surgery and in pre-
dicting possible complications or recurrencies. Imaging 
techniques such as Ultrasound (US), Magnetic Reso-
nance Imaging (MRI) and Computed Tomography (CT) 
are frequently used for the evaluation of parotid lesions, 
although none of them can guarantee an accurate differ-
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Aims: To evaluate the pre-surgical diagnostic value of Multiparametric Ultrasound (MPUS) and Fine Needle Aspiration 
Cytology (FNAC) in differentiating parotid gland tumors, comparing the results with histology. Materials and methods: 
The study enrolled 84 patients with parotid gland lesions surgically treated in a single tertiary center and evaluated by MPUS. 
Each patient underwent FNAC. Histological examination was considered the gold standard. Results: Histology identified 62 
benign tumors and 22 malignancies. In the differential diagnosis between malignant and benign lesions, B-mode Ultrasound 
(US), Color-Doppler US, Contrast-Enhanced US (CEUS), Elastography (USE) and FNAC showed the following values of 
sensitivity: 82%, 81%, 86%, 77%, 73% respectively; specificity: 97%, 61%, 95%, 71%, 97% respectively; PPV: 90%, 43%, 
86%, 50%, 89% respectively; NPV: 93%, 90%, 95%, 88%, 91% respectively; and accuracy: 89%, 71%, 90%, 78%, 84% re-
spectively. Conclusions: CEUS proved to be a valid and accurate method for identifying malignant tumors of parotid gland; 
the combination of B-mode US with CEUS showed similar diagnostic accuracy, but better sensitivity than CEUS taken alone. 
USE did not improve the diagnostic performance of the B-mode US, alone or in association with CEUS; however, it revealed 
the highest diagnostic accuracy in the differentiation between benign lesions. FNAC demonstrated lower values in comparison 
with CEUS and with USE. Therefore, according to our study, MPUS could be proposed as a valid alternative to FNAC.
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ential diagnosis between benign lesions and malignan-
cies [1]. The sensitivity and specificity of Fine Needle 
Aspiration Cytology (FNAC) varies according to lesion 
location and size, and the pathologist’s experience. Fur-
thermore, FNAC may be non-diagnostic, and the patients 
need a second FNAC to achieve a diagnosis [12,13]. 
Therefore, to date, the gold standard in the diagnosis of 
salivary gland neoplasms remains surgical excision fol-
lowed by histopathology.
Recently, some authors have focused on US coupled 
with various innovative techniques, under the name of 
Multiparametric Ultrasound (MPUS) [14]. These tech-
niques, such as Contrast-Enhanced Ultrasound (CEUS) 
and Ultrasound-Elastography (USE), are used to increase 
the effectiveness and the accuracy of B-mode US in the 
differential diagnosis of parotid masses and decrease the 
need for invasive techniques [1,2].
The aim of our study was to evaluate the diagnostic 
accuracy of MPUS, with CEUS and USE, and of FNAC 
in differentiating parotid gland tumors, comparing the re-
sults with post-surgical histology.
Materials and methods
Eighty-four consecutive patients (36 female and 48 
male patients, age range = 20-78 years, mean age = 49 
years) with parotid neoplasms presented to the Otolar-
yngology and Maxillofacial Surgery Departments of our 
University Hospital between September 2018 and Octo-
ber 2020 were included in the study. All subjects pro-
vided written informed consent. The research was con-
ducted in accordance with the ethical guidelines of the 
Helsinki Declaration and the Internal Review Board of 
our University Hospital approved it. 
Patients were studied preoperatively using B-mode 
US, Color-Doppler US, CEUS, USE and FNAC. Subse-
quently, patients were treated surgically with extracap-
sular dissection or superficial parotidectomy in cases of 
suspected benign tumor and total parotidectomy in case 
of presumed malignancy (with or without lymph node 
dissection according to histological subtype and tumor 
extension). The surgical samples were analyzed by an 
anatomo-pathologist and histopathology results com-
pared to the above-mentioned diagnostic techniques.     
B-mode US and Color-Doppler US
US evaluation was performed using a “high-end” ma-
chine (Canon Medical Systems Aplio 500, i800 US sys-
tem, formerly Toshiba Medical Systems, Otawara, Japan) 
and a 5-14 MHz linear probe by a single radiologist with 
15 years of experience in CEUS and 10 years in USE.
The patients were placed in supine position, with a pil-
low placed under the shoulders, to obtain neck hyperex-
tension. Bilateral axial and sagittal images were acquired. 
The size, the shape, the margins of the lesions and the 
vascularization with Color-Doppler US were recorded.
The following patterns were considered at the evalu-
ation with baseline ultrasound: 1) suspected malignant 
lesions: nodular appearance, irregular or frankly infiltrat-
ing margins, heterogeneous hypoechoic structure, calci-
fications and hypo-anechoic necrotic-hemorrhagic inter-
nal areas, associated regional lymphadenopathy [1,15]; 
2) pleomorphic adenoma: homogeneous, lobulated, hy-
poechoic structure with posterior wall enhancement, with 
or without calcifications, poor vascularization [1,16]; 
3) Warthin’s tumor: oval, hypoechoic mass, capsulated 
with anechoic and hypervascularized areas [1,17,18].
In the evaluation with Color-Doppler US, the follow-
ing patterns were considered: Type 1 - marked and ir-
regular intralesional blood flow; Type 2 - homogeneous 
flow or mild and peripheral vascularization. Type 1 pat-
tern was considered more typical of malignant lesions, 
while Type 2 of benign ones.
We also tried to identify a specific pattern of vascu-
larization in order to distinguish between benign lesions 
as follows: marked and homogeneous vascularization for 
Warthin’s tumor while mild and peripheral flow for pleo-
morphic adenoma [19-21].
USE
USE was performed using a semi-quantitative qua-
sistatic technique by the same experienced radiologist.
The patients were asked not to move and rhythmic 
compressions were performed for 3-4 seconds in order 
to allow the acquisition of data. Then, the operator per-
formed the examination using longitudinal scans and 
checking a quality indicator in real time; a colorimetric 
scale on the screen indicated the correspondence between 
hard and soft areas, respectively shown with blue and red 
colors and subsequently, the operator placed two regions 
of interest (ROI), one in the nodule and another one in the 
adjacent gland tissue. The USE software then calculated 
the strain ratio [22-26].
CEUS 
A medical history was collected for each patient, aim-
ing to exclude contraindications for the US contrast me-
dium administration [27-30]. 
CEUS was performed after intravenous administra-
tion of 2.4 mL of contrast medium (SonoVueTM, Brac-
co, Milan, Italy) followed by 10 ml of isotonic saline so-
lution. The CEUS study was carried out for at least two 
minutes, using low mechanical index (MI 0.05-0.07). 
The procedure was recorded digitally on AVI files in or-
der to perform a qualitative analysis.
After CEUS examination, lesions were divided in two 
categories (type 0-1), using a classification system that 
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originates from the studies by Wei et al [30] and from 
David et al [2].
For CEUS, the following patterns were considered: 
Type 0 – a) homogeneous enhancement of the lesion; 
b) heterogeneous enhancement but with defined margins; 
c) no enhancement and iso-enhancement; Type 1: hetero-
geneous enhancement of the tumor with poorly defined 
margins.  Type 0 pattern was considered more typical of 
benign lesions, while Type 1 of malignant ones.
All patients underwent Fine Needle Aspiration Cytol-
ogy (FNAC), surgery and histopathological examination. 
Statistical analysis 
Statistical analysis was carried out by calculating, for 
each method, sensitivity, specificity, positive and nega-
tive predictive value and area under the ROC curve. The 
ROC curve and the Youden test were used to identify the 
optimal strain ratio cut-off to discriminate between be-
nign and malignant lesions and, within benign lesions, 
between pleomorphic adenomas and Warthin’s tumors. 
The comparison between the performances of the various 
US methods was performed by comparing the areas un-
der the ROC curves (AUC) through the Bonferroni test. 
The analysis was performed using the STATA 15 statisti-
cal package.
Results
Post-operative histopathology analysis revealed be-
nign tumors in 62 patients (73.8%) and malignant tumors 
in 22 patients (26.2%). The average size of the evaluated 
lesions was 25 mm, with a range between 3 mm and 55 
mm. 
Histological results were as follows: Warthin’s tu-
mor 33.3.% (n=28), pleomorphic adenoma 19% (n=16), 
acinic cell carcinoma 7.1% (n=6), primary squamous cell 
carcinoma 7.1% (n=6), non-specific inflammation 7.1% 
(n=6), benign vascular tumor 4.8% (n=4), non-Hodgkin 
type B lymphoma 4.8% (n=4), metastasis from squamous 
cell carcinoma 2.4% (n=2), carcinoma ex-pleomorphic 
adenoma 2.4% (n=2), poorly differentiated carcinoma 
2.4% (n=2), mucoepidermoid carcinoma 2.4% (n=2), 
lymphoepithelial cysts 2.4% (n=2), oncocytoma (2.4% 
(n=2), ductal cyst 1.2% (n=1), papillary oncocytic cys-
tadenoma 1.2% (n=1).
Differentiation between malignant and benign 
lesions
B-mode US showed 62 of 64 benign tumors and 20 of 
22 histologically proven malignant lesions.
Color-Doppler US evaluation detected benign neo-
plasm in 42 cases, 4 of which were malignant and 38 
were benign at histology, and malignant lesions in 42 
cases (Type 1), 18 of which were malignant and 24 be-
nign at histology.
CEUS highlighted 60 benign cases (type 0 pattern) 
of 64 resulted being benign at histology and 18 malig-
nant lesions (type 1 pattern) out of 22 malignant tumors 
at histology.
USE detected 45 of 64 benign lesions and 17 of 22 
malignant ones. 
Cytology (FNAC) identified 60 of 64 benign tumors 
and revealed 16 of 22 malignant cases. 
The results of sensibility, specificity, positive predic-
tive value (PPV), negative predictive value (NPV) and 
accuracy in the differential diagnosis between malignant 
and benign lesions of the techniques taken alone and in 
combination are summarized in Table I.
Diagnostic differentiation of benign lesions
The same methods were used to differentiate between 
Warthin’s tumor 33.3% (n=28) and pleomorphic adeno-
ma 19% (n=16). Our results showed that CEUS had a 
Table I. Performance of the ultrasound techniques in the differentiation between parotid gland benign and malignant lesions.
Se (%) Sp (%) PPV (%) NPV (%) Ac (%)
B-mode US 82 97 90 93 89
Color-Doppler US 81 61 43 90 71
CEUS 86 95 86 95 90
USE 77 71 50 88 78
FNAC  73 97 89 91 84
B-mode US + CEUS 95 54 63 88 86
B-mode US + USE 78 80 46 84 72
Color-Doppler US + CEUS 83 76 58 91 82
Color-Doppler US + USE 78 69 46 88 75
USE + CEUS 86 69 50 90 78
US, Ultrasound; Color-Doppler US, Color-Doppler Ultrasound; CEUS, Contrast-Enhanced Ultrasound; USE, Ultrasound-Elastography; 
FNAC, Fine Needle Aspiration Cytology; SE, Sensibility; Sp, Specificity; PPV, Predictive Positive Value; NPV, Negative Predictive Value; 
Ac, Accuracy.
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slightly higher diagnostic accuracy (80%) compared to 
B-mode US alone, which had a diagnostic accuracy of 
78%.
USE’s accuracy, as well as specificity, increased with 
lesion diameter: it was lower in lesions ≤1 cm and in-
creased progressively in lesions between 1.1 cm and 1.9 
cm and in lesions ≥2 cm (ROC areas: 30% ≤1 cm; 45% 
1.1-1.9 cm; 53% ≥2 cm; specificity: 60%  ≤1 cm; 90% 
1.1-1.9 cm; 97% ≥2 cm).
Regarding USE, the Youden test identified the cut-
off of 2.5 as the value that optimized the ability of the 
method to discriminate between pleomorphic adenoma 
and Warthin’s tumor, with values lower than 2.5 more 
associated with Warthin’s tumor. In this case, the USE’s 
accuracy was higher compared to CEUS and B-mode US 
(85% against 80% and 78%, respectively).
All the statistical results are summarized in Table II. 
It is worth nothing that USE resulted being the most ef-
fective technique for the differentiation of pleomorphic 
adenoma from Warthin’s tumor. 
In figures 1-3 are illustrated significant cases from 
our database.
Discussion
B-mode US, used routinely in clinical practice, al-
lows the identification and location of parotid lesions 
and the depiction of their inner structure. However, a 
more accurate and detailed representation of the blood 
flow patterns, in particular a quantitative analysis of 
micro-vascular perfusion, of the different lesions can be 
achieved with CEUS [2,14,27]. 
There is still limited evidence on the use of CEUS 
in the parotid gland neoplasms. In the latest edition of 
the European Federation of Societies for Ultrasound in 
Medicine and Biology (EFSUMB) guidelines, no clinical 
recommendation was possible, even though they recog-
nized a research role [29]. Nevertheless, recent studies 
showed a promising perspective of CEUS. Wei et al in 
2013 defined the usefulness of CEUS in the evaluation 
of micro-vascularization of the lesion according to the 
morphological and distribution characteristics of the 
vascular pattern. The results of this study showed that 
benign lesions present mainly with widespread homo-
geneous enhancement with clearly defined margins or 
no enhancement and iso-enhancement, while malignant 
tumors mainly show heterogeneous enhancement with 
poorly defined margins [30].
USE provides information about the elasticity/rigid-
ity patterns of gland tissues, which correlate with the 
composition and structural organization of macromol-
ecules [31,32]. Currently, it may have a role in differenti-
ating the most common benign parotid lesions. USE also 
has a role in differentiating between benign and malignat 
parotids tumors.
Elastographic technique has already been evaluated 
for the characterization of the head-neck lesions, with 
different results. Bathia et al [33] have reported that USE 
does not allow to differentiate the tumors, since areas that 
show the same stiffness can be found in lesions that pre-
sent a different histology. Dumitriu et al [16] reported 
the absence of any elastographic pattern that could define 
the malignant or benign nature of a lesion, observing lit-
tle benefits in differentiating parotid tumors, particularly 
regarding the quantitative values of the pleomorphic ad-
enoma which presented similar results to malignant tu-
mors. In particular, the authors observed an intra-lesional 
variability of rigidity, which may be high in the pleomor-
phic adenoma due to the heterogeneity of the tissue, con-
cluding that USE in the parotid gland is not a valid tool 
to exclude malignancy. Contrarily, a meta-analysis from 
2016 evaluated the results of 9 studies without publica-
Table II. Performace of the ultrasound methods in the differentiation between pleomorphic adenoma and Warthin’s tumor
Se (%) Sp (%) PPV (%) NPV (%) Ac (%)
B-mode US 76 78 64 86 78
Color-Doppler US 60 85 69 80 71
CEUS 81 87 74 86 80
USE 93 81 69 96 85
FNAC 57 96 79 71 76
B-mode US + CEUS 72 82 64 87 76
B-mode US + USE 70 76 50 88 73
Color-Doppler US + CEUS 95 37 63 88 66
Color-Doppler US + USE 60 77 57 80 68
USE + CEUS 83 85 68 86 82
US, Ultrasound; Color-Doppler US, Color-Doppler Ultrasound; CEUS, Contrast-Enhanced Ultrasound; USE, US-Elastography; FNAC, 
Fine Needle Aspiration Cytology; SE, Sensibility; Sp, Specificity; PPV, Predictive Positive Value; NPV, Negative Predictive Value; 
Ac, Accuracy.
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tion bias regarding the use of this US method for the dif-
ferentiation of 581 benign and malignant salivary gland 
lesions, highlighting good sensitivity and specificity val-
ues (76% and 73%, respectively). The results showed 
that malignant lesions were commonly harder than be-
nign ones. The authors suggested USE in addition to the 
conventional US for the evaluation of the salivary gland 
tumors; however, the general accuracy of USE could not 
obviate the need for biopsy [34]. 
In the study by Klintworth et al, authors suggested the 
presence of some specific elastographic patterns useful in 
the differentiation between parotid gland tumors. In our 
work, we did not take into account these patterns, lim-
iting our evalutation to numerical elastographic values 
[23]. Other authors reported on the use of Shear Wave 
Elastography (SWE) also in this setting; however, we did 
not assess SWE effectiveness in our study and it is still 
under debate which is the best technique between USE 
or SWE. Mansour et al reported that SWE was better for 
discriminating parotid gland diseases such as Sjogren’s 
syndrome than to differentiate parotid gland lesions [24]; 
Heřman J et al suggested that SWE acceptably distin-
Fig 1. Parotid gland hypoechoic lesion, oval-shaped, with well defined margins and poor vascularization at Color-Doppler US (a,b). 
The lesion appeared moderately stiff at USE (SR 3.40); c) and showed slight enhancement at CEUS (d). Histology showed pleomor-
phic adenoma.
Fig 2. Well-defined parotid gland lesion, heterogeneous with some cystic areas (a), with peripheral and internal vascularization at 
Color-Doppler US evaluation (b). The lesion appeared mainly soft at USE, with stiff portions corresponding to the cystic areas (c). 
CEUS showed periferal perfusion (d). The lesion was histologically shown to be a Warthin’s tumor.
Fig 3. Parotid gland lesion, mostly hypoechoic with undefined margins (a) and increased stiffness at USE (SR 4.976; b). At CEUS 
evaluation the tumor showed rapid uptake of the contrast during the arterial phase, followed by a rapid wash-out at the end of the 
arterial phase. The enhancement curve is suggestive for malignancy (c,d). Histology showed acinic cell carcinoma.
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guished benign from malignant lesions on its own but 
did not bring additional value in the characterization of 
parotid gland tumors when used as an adjunct to regular 
US examination [35]. Zengel et al [25] and Liu et al [26] 
reported different results. In addition, a recent paper pub-
lished by Jering et al [36] showed the importance of USE 
(especially SWE) in differentiating benign from malig-
nant tumors, suggesting that the hard part of the lesion is 
larger in malignant tumors than in benign pleomorphic 
adenomas that usually have only a hard central area of 
increased stiffness. 
In this study, we evaluated the diagnostic accuracy 
of MPUS with CEUS and USE in pre-surgical differen-
tiation of parotid tumors comparing the results with B-
mode US, Color-Doppler US and FNAC. MPUS evalua-
tion seems the most promising approach to preoperative 
diagnosis of parotid neoplasms. In 2015, Mansour et al 
studied 202 patients with parotid lesions, documenting 
their clinical history, clinical examination, B-mode US, 
USE, Color-Doppler and CEUS. They concluded that 
there was a correlation between the micro- and the mac-
ro-vascularization of the lesions respectively evaluated 
with CEUS and Color-Doppler US, but the predictive 
value of each single technique was not so effective and a 
multiparametric assessment was required to increase the 
specificity and PPV in the diagnosis of malignant parotid 
lesions and the sensitivity in the differential diagnosis be-
tween pleomorphic adenomas and Warthin’s tumors [37]. 
Another recent review confirmed that MPUS, specially 
if includes CEUS, enables the differential diagnosis of 
parotid tumors [1,20].
Concerning USE, in our study, a statistically signifi-
cant difference in elasticity between benign and malig-
nant tumors was identified. The ROC analysis showed 
that, for malignancy diagnosis, the cut-off value of SR 
is >3. However, the method presented poor sensitivity 
(77%) and poor diagnostic accuracy (78%), mostly due to 
the presence of non-Hodgkin’s lymphomas (n=4), which 
has elasticity similar to most benign parotid lesions.  
Lesions studied with CEUS were classified into dif-
ferent types, similar to the study by Wei et al [30] and 
David et al [2], based on vascularization patterns. Sub-
sequently, these patterns were compared with histologi-
cal examination. This allowed us to create criteria for the 
assignment of a given pattern for malignant lesions and 
for benign lesions: type 0 pattern was more frequently 
associated with benign lesions and type 1 pattern with 
malignant ones.
Our study showed that CEUS has high diagnostic ac-
curacy (90%), sensitivity (86%) and specificity (95%) 
and may be considered the optimal method for differ-
entiating between benign and malignant lesions. These 
results prove also the superiority of CEUS in terms of 
sensitivity, specificity and accuracy compared to stand-
ard methods, especially if compared to FNAC, still used 
today as the main exam in the patient’s pre-operative 
planning. Indeed, FNAC was less accurate than B-mode 
US and CEUS, with a high percentage of non-diagnostic 
results and low sensitivity.
Among the various combined statistical evaluations, 
our results showed that the association of B-mode US 
with CEUS had the best performance, presenting with 
similar accuracy of CEUS taken alone, but with better 
sensitivity (95%).
Our results also confirmed that B-mode US is an 
important technique in the preoperative diagnosis, pre-
senting high diagnostic accuracy (89%), in line with the 
literature [1,15,16,19,33,36,38]. However, being an oper-
ator-dependent examination, the results are linked to the 
execution by an experienced operator, especially in the 
study of the major salivary glands.
Color-Doppler US examination allowed us to evalu-
ate the vascularization of the lesions, but it proved to 
be ineffective in discriminating benign from malignant 
tumors, showing a low diagnostic accuracy, thus result-
ing in a poor diagnostic value. This result may be due 
to the considerable overlap between Color-Doppler char-
acteristics, especially between benign and low-grade 
malignant lesions, as recently confirmed by Knopf et al 
[39].
The elastographic method with cut-off SR >3, pre-
senting a diagnostic accuracy of 78%, appeared to be less 
performing than CEUS and of limited diagnostic value 
in differentiating malignant lesions from benign ones, 
in line with recent studies [1,16,33,40,41]. These results 
are probably due to the presence in the diagnostic sample 
of non-Hodgkin’s lymphomas which have an elasticity 
comparable to that of benign parotid tumors. 
Our results are in concordance with current literature 
that indicates that Warthin´s tumor is the most common 
benign parotid tumor [42]. In the characterization be-
tween the two most common benign tumors, USE proved 
to be statistically superior to the other methods. USE 
showed diagnostic accuracy of 85%, much higher than 
that of B-mode US (78%) and CEUS (80%). Notewor-
thy, USE had an excellent reliability in differentiating 
Warthin’s tumor from pleomorphic adenoma.
Our study has some limitations. Firstly, our results 
are based on a limited sample size; therefore, larger stud-
ies are required. Secondly, we relied on the accuracy of 
pathological diagnosis excluding patients who had not 
undergone surgery. Finally, we did not use SWE neither 
did we perform a comparison between MPUS and MRI 
[43].
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Conclusions
Our results suggest that the combination of B-mode 
US and CEUS greatly improved the sensitivity of the 
CEUS performed individually and presented remarkable 
accuracy, with the potential to reduce the number of inva-
sive procedures. USE may have a role in differentiating 
benign from malignat parotid tumors, but especially in 
differentiating Warthin’s tumor from pleomorphic ad-
enoma. FNAC demonstrated lower values in comparison 
with CEUS in the differentiation between malignant and 
benign neoplasms and with USE in the diagnostic differ-
entiation of benign lesions. 
Therefore, MPUS could be proposed as a valid alter-
native to FNAC; however, multicenter studies on a larger 
population, eventually including a comparison with MRI, 
are mandatory. 
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